Literature DB >> 29242141

Molecular and epidemiological evidence of patient-to-patient hepatitis C virus transmission in a Scottish emergency department.

I Johannessen1, J Danial2, D B Smith3, J Richards2, L Imrie4, A Rankin4, L J Willocks5, C Evans5, C Leen6, P Gibson7, P Simmonds8, D Goldberg9, A McCallum5, K Roy9.   

Abstract

BACKGROUND: Transmission of hepatitis C virus (HCV) in the healthcare setting is rare. Routine infection prevention and control measures mean that this should be a preventable 'never event'. AIM: To investigate the diagnosis of acute healthcare-associated HCV infection.
METHODS: Epidemiological and molecular investigation of a case of acute HCV infection associated with nosocomial exposure.
FINDINGS: Detailed investigation of the treatment history of a patient with acute HCV infection identified transmission from a co-attending patient in an emergency department as the likely source; this possibility was confirmed by virus sequence analysis. The precise route of transmission was not identified, though both patient and source had minimally invasive healthcare interventions. Review of infection, prevention and control identified potentially contributory factors in the causal pathway including hand hygiene, inappropriate use of personal protective equipment, and blood contamination of the surface of the departmental blood gas analyser.
CONCLUSION: We provide molecular and epidemiological evidence of HCV transmission between patients in an emergency department that was made possible by environmental contamination. Patients with HCV infection are higher users of emergency care than the general population and a significant proportion of those affected remain unknown and/or infectious. Equipment, departmental design, staff behaviour, and patient risk require regular review to minimize the risk of nosocomial HCV transmission.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Emergency department; Hepatitis C virus; Surveillance; Transmission

Mesh:

Year:  2017        PMID: 29242141     DOI: 10.1016/j.jhin.2017.12.006

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

1.  Beware of HCV and HEV in Patients with Suspected Drug-Induced Liver Injury.

Authors:  Priya Grewal; Jawad Ahmad
Journal:  Curr Hepatol Rep       Date:  2018-07-11

2.  The prevalence of HCV RNA positivity in anti-HCV antibodies-negative hemodialysis patients in Thrace Region. Multicentral study.

Authors:  Eleni I Konstantinidou; Eftychia G Kontekaki; Aristidis Kefas; Theocharis Konstantinidis; Gioulia Romanidou; Eleni Fotiadou; Viki Rekari; Eleni Triantafyllidou; Stavroula Zisaki; Evi Kasmeridou; Mariana Andreadou; Konstantina Kantartzi; Konstantinos Mavromatidis; George Martinis; Dimitrios Cassimos; Elias Thodis; Maria Panopoulou; Konstantinos Mimidis
Journal:  Germs       Date:  2021-03-15

3.  NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients.

Authors:  Maria Concetta Bellocchi; Marianna Aragri; Luca Carioti; Lavinia Fabeni; Rosaria Maria Pipitone; Giuseppina Brancaccio; Maria Chiara Sorbo; Silvia Barbaliscia; Velia Chiara Di Maio; Fabrizio Bronte; Stefania Grimaudo; Walter Mazzucco; Ferdinando Frigeri; Marco Cantone; Antonio Pinto; Carlo Federico Perno; Antonio Craxì; Giovanni Battista Gaeta; Vito Di Marco; Francesca Ceccherini-Silberstein
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.